NEW YORK CITY (dpa-AFX) - Pfizer Inc. has signed an agreement to extend and
expand access to Cadence products and programming toolkits for advanced
molecular design, Cadence Molecular Sciences, a business unit of Cadence Design
Systems (CDNS), said in a statement.

Cadence Molecular Sciences' physics-and AI-based modeling and cheminformatics
computational software is an enabler of early-stage drug discovery innovation.
The software is used by major pharmaceutical and biotech companies worldwide to
help accelerate and advance therapeutic research, Cadence said.



Copyright(c) 2023 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX